NVIV - InVivo Therapeutics Holdings Corp.
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Annual
| Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
| Total Revenue | - | - | - | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | ||||
| Research Development | 10,373 | 12,557 | 10,058 | 10,894 |
| Selling General and Administrative | 13,322 | 11,506 | 12,340 | 7,566 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 23,695 | 24,063 | 22,398 | 18,460 |
| Operating Income or Loss | -23,695 | -24,063 | -22,398 | -18,460 |
| Income from Continuing Operations | ||||
| Total Other Income/Expenses Net | -3,050 | 625 | -10,916 | 114 |
| Earnings Before Interest and Taxes | -23,695 | -24,063 | -22,398 | -18,460 |
| Interest Expense | -74 | -155 | -172 | -136 |
| Income Before Tax | -26,745 | -23,438 | -33,314 | -18,346 |
| Income Tax Expense | - | - | - | - |
| Minority Interest | - | - | - | - |
| Net Income From Continuing Ops | -26,745 | -23,438 | -33,314 | -18,346 |
| Non-recurring Events | ||||
| Discontinued Operations | - | - | - | - |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income | ||||
| Net Income | -26,745 | -23,438 | -33,314 | -18,346 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | -26,745 | -23,438 | -33,314 | -18,346 |
